Results 211 to 220 of about 715,584 (321)
The Size-Growth Rate Relationship in Hepatocellular Carcinoma. [PDF]
Gnanendran D +5 more
europepmc +1 more source
Epidermal growth factor‐induced increases in inositol trisphosphates, inositol tetrakisphosphates, and cytosolic Ca2+ in a human hepatocellular carcinoma‐derived cell line [PDF]
Ann Gilligan +3 more
openalex +1 more source
EM2 directly binds to and activates MST1/2, enhancing their kinase activity and sequentially promoting LATS phosphorylation, which increases YAP phosphorylation. Consequently, YAP nuclear translocation is suppressed, leading to reduced transcription of downstream targets CTGF and CYR61, ultimately exerting a robust inhibitory effect on NSCLC cell ...
Siyu Yang +15 more
wiley +1 more source
Are we overestimating success of salvage hepatectomy in unresectable hepatocellular carcinoma? [PDF]
Meena BL, Sharma D.
europepmc +1 more source
Identification of TPRA1 as a Novel Receptor and Predictive Biomarker for Oncolytic Virus M1
This study identifies transmembrane protein adipocyte‐associated 1 (TPRA1) as a novel receptor for oncolytic virus M1 (OVM). TPRA1's ectodomain binds OVM particles, while its intracellular domain facilitates virus internalization, promoting efficient viral entry.
Linyi Hu +20 more
wiley +1 more source
Evaluation and prediction of Ki-67 expression in hepatocellular carcinoma. [PDF]
Jagtap SV.
europepmc +1 more source
Splenoportographic Findings of Hepatocellular Carcinoma
Atsushi Toyonaga +10 more
openalex +2 more sources
CD161 is identified as a novel inhibitory receptor on bone marrow (BM)‐resident CD8⁺ T cells in multiple myeloma (MM). Through interaction with its ligand CLEC2D, CD161 impairs T‐cell function and promotes immune suppression. Blockade of CD161 restores tissue residency and cytotoxicity of CD8⁺ T cells and enhances chimeric antigen receptor T‐cell (CAR ...
Liwen Wang +16 more
wiley +1 more source

